Tag: Antipsychotics

Researchers highlight how systematic reviews are compromised by pharmaceutical industry ties by exposing a study of injectable antipsychotics.

Bergner’s piece in The New York Times challenged the illusions of psychiatry. That made some people angry, outraged, or scared. The result is their comments section.

New research reveals that patients are often not given fully informed consent before being prescribed antipsychotics.

Withholding antipsychotics may be beneficial for memory, the researchers write.

“Patients expressed feeling unaccepted by society or uncomfortable in their own skin… A few indicated that they would rather be dead than have tardive dyskinesia.”

Long-term exposure to prolactin-increasing antipsychotics increases the odds of developing breast cancer.

Researchers developed a rating scale to better assess service users’ experiences tapering antidepressant and/or antipsychotic medication.

In JAMA psychiatry, researchers outline new theories connecting antipsychotic use in people with schizophrenia and increased dementia risk.

Research suggests that slowly tapering off an antipsychotic reduces the risk of withdrawal psychosis compared to abrupt discontinuation.

Researchers push for a renewed focus on true shared decision-making for patients diagnosed with psychosis.

Researchers question the long-term use of antipsychotics and suggest increased research and investment in psychosocial interventions.

It requires extraordinary mental gymnastics by psychiatrists to conclude that neuroleptics, which cause obesity, metabolic dysfunction, diabetes, tardive dyskinesia, lethal cardiac arrhythmias, and so on, protect against death.

The recent report by the BBC on medication-free treatment in Norway, when viewed in conjunction with the media silence on Martin Harrow's latest publication, reveals why the public remains misinformed about the long-term effects of antipsychotics.

People with "serious mental illness" who stop taking antipsychotics are more likely to recover, even when accounting for baseline severity.

Our new discussion series aims to explore what we do and don’t know about safe withdrawal from antidepressants, antipsychotics, benzodiazepines and stimulants.

Psychiatry has long turned a blind eye to the full scope of harm associated with TD. New TD drugs "work" by further impairing brain function.

The increased prescribing of antipsychotics, which frequently cause a brain injury that manifests as tardive dyskinesia, has provided pharmaceutical companies with a lucrative new market opportunity.

A new study finds that adding an antipsychotic to existing antidepressant treatment is associated with a 45% increased risk of early death.

An article in JAMA Psychiatry advises very slow tapering for best results when discontinuing antipsychotic drugs.

Psychiatry has a history of continuing to perform harmful, even deadly procedures. But does it still happen? Medication-induced akathisia filled two and a half pages of the DSM-IV. Why was it written out of the DSM 5?

A new study has found a strong association between antipsychotic drugs and higher rates of severe cases of COVID-19.

Researchers studied whether antipsychotics could prevent transition to full psychosis and found that the drugs worsened outcomes.

A new study published in JAMA Psychiatry connects antipsychotics with damage to the brain in multiple areas.

Are those diagnosed with “mental illness” more dangerous than other people? Or have we evolved to sense danger from anything that we believe to be different or "strange"?

Researchers find that most psychiatric drugs cause severe withdrawal despite attempt s to gradually decrease the dosage.